BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25071087)

  • 1. Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.
    Zhou L; Li Y; He W; Zhou D; Tan RJ; Nie J; Hou FF; Liu Y
    J Am Soc Nephrol; 2015 Mar; 26(3):677-91. PubMed ID: 25071087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
    Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
    FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy.
    Wan J; Hou X; Zhou Z; Geng J; Tian J; Bai X; Nie J
    Free Radic Biol Med; 2017 Jul; 108():280-299. PubMed ID: 28315733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMIP interacts with WT1 and targets it on the proteasome degradation pathway.
    Zhang SY; Fan Q; Moktefi A; Ory V; Audard V; Pawlak A; Ollero M; Sahali D; Henique C
    Clin Transl Med; 2021 Jul; 11(7):e460. PubMed ID: 34323419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
    Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
    Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
    Jing Z; Wei-jie Y; Yi-Feng ZG
    Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
    Zhou D; Wang Y; Gui Y; Fu H; Zhou S; Wang Y; Bastacky SI; Stolz DB; Liu Y
    Kidney Int; 2022 Jul; 102(1):96-107. PubMed ID: 35341792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.
    Zhou L; Liu Y
    Nat Rev Nephrol; 2015 Sep; 11(9):535-45. PubMed ID: 26055352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
    Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
    Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
    [No Abstract]   [Full Text] [Related]  

  • 10. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
    Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
    J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.
    Buelli S; Rosanò L; Gagliardini E; Corna D; Longaretti L; Pezzotta A; Perico L; Conti S; Rizzo P; Novelli R; Morigi M; Zoja C; Remuzzi G; Bagnato A; Benigni A
    J Am Soc Nephrol; 2014 Mar; 25(3):523-33. PubMed ID: 24371298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miRNA-671-5p in Mediating Wnt/β-Catenin-Triggered Podocyte Injury.
    Wang C; Liu J; Zhang X; Chen Q; Bai X; Hong X; Zhou L; Liu Y
    Front Pharmacol; 2021; 12():784489. PubMed ID: 35111054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
    He W; Kang YS; Dai C; Liu Y
    J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy.
    Xie K; Xu C; Zhang M; Wang M; Min L; Qian C; Wang Q; Ni Z; Mou S; Dai H; Pang H; Gu L
    Cell Death Dis; 2019 Dec; 10(12):915. PubMed ID: 31801948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
    Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling.
    Zhang H; Ren R; Du J; Sun T; Wang P; Kang P
    Kidney Blood Press Res; 2017; 42(5):794-803. PubMed ID: 29069662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
    Guo N; Guo J; Su D
    Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway.
    Miao H; Wang YN; Su W; Zou L; Zhuang SG; Yu XY; Liu F; Zhao YY
    Acta Pharmacol Sin; 2024 Jan; 45(1):137-149. PubMed ID: 37640899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria.
    Zhou L; Chen X; Lu M; Wu Q; Yuan Q; Hu C; Miao J; Zhang Y; Li H; Hou FF; Nie J; Liu Y
    Kidney Int; 2019 Apr; 95(4):830-845. PubMed ID: 30770219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.
    Mo H; Wu Q; Miao J; Luo C; Hong X; Wang Y; Tang L; Hou FF; Liu Y; Zhou L
    Antioxid Redox Signal; 2017 Aug; 27(6):345-362. PubMed ID: 27960539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.